Skip to content

Pulsed US Versus SWD in Carpal Tunnel Syndrome

Pulsed Ultrasound Versus Pulsed Shortwave Diathermy in Mild-to-Moderate Carpal Tunnel Syndrome: A Randomized Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07545161
Enrollment
40
Registered
2026-04-22
Start date
2025-03-11
Completion date
2025-09-15
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal Tunnel Syndrome, Physical Therapy Modalities, Ultrasound Therapy

Keywords

Carpal tunnel syndrome, ultrasonography, diathermy, median nerve, randomized controlled trial

Brief summary

The goal of this clinical trial is to compare two physical therapy treatments in people with mild-to-moderate carpal tunnel syndrome (CTS). CTS is a condition that causes pain, numbness, and weakness in the hand. The main question this study aims to answer is: Does pulsed ultrasound or pulsed shortwave diathermy lead to greater improvement in symptoms and nerve swelling when added to standard treatment? All participants will receive standard conservative treatment, including a wrist splint and nerve and tendon gliding exercises for three weeks. In addition, participants will be randomly assigned to receive one of the following treatments: Pulsed therapeutic ultrasound (US) Pulsed shortwave diathermy (SWD) Researchers will measure changes in hand symptoms, pain levels, grip strength, and the size of the median nerve using ultrasound imaging. Assessments will be performed before treatment, and at 1 month and 3 months after treatment. The primary outcome of the study is the change in median nerve cross-sectional area at 3 months.

Detailed description

Carpal tunnel syndrome (CTS) is the most common entrapment neuropathy of the upper extremity and is characterized by pain, numbness, and hand weakness. Conservative treatment is recommended as first-line therapy in patients with mild-to-moderate CTS and commonly includes wrist splinting and nerve and tendon gliding exercises. Physical therapy modalities are frequently added to improve clinical outcomes. This randomized, assessor-blinded, parallel-group clinical trial was conducted between March 2025 and Sep 2025. Forty participants with electrophysiologically confirmed mild-to-moderate CTS were randomly assigned to one of two intervention groups. All participants received standard conservative treatment consisting of neutral-position wrist splinting and tendon-nerve gliding exercises for three weeks. In addition to standard treatment, one group received pulsed therapeutic ultrasound (US) and the other group received pulsed shortwave diathermy (SWD), administered in 15 sessions over three weeks. Outcome measures were assessed at baseline, 1 month, and 3 months. The primary outcome was the change in median nerve cross-sectional area measured by ultrasonography at 3 months. Secondary outcomes included symptom severity and functional status assessed by the Boston Carpal Tunnel Questionnaire (BCTQ), pain intensity measured by the Visual Analog Scale (VAS), neuropathic pain assessed using the DN4 questionnaire, and hand grip strength measured with a dynamometer. The study was designed to compare the clinical and structural effects of pulsed US and pulsed SWD when added to standard conservative treatment in mild-to-moderate CTS.

Interventions

DEVICEPulsed Therapeutic Ultrasound

Pulsed therapeutic ultrasound was applied to the volar aspect of the wrist using a frequency of 3 MHz, an intensity of 0.8 W/cm², and a pulse ratio of 1:4 for 5 minutes per session. A total of 15 treatment sessions were administered over three weeks.

DEVICEPulsed Shortwave Diathermy

Pulsed shortwave diathermy was applied with electrodes positioned parallel to the volar and dorsal aspects of the wrist, centered at the distal palmar crease. Treatment was delivered in pulsed mode at a frequency of 80 Hz and a mean output power of 19.2 W for 15 minutes per session. A total of 15 sessions were administered over three weeks.

Sponsors

Kahramanmaras Sutcu Imam University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Outcome assessments, including ultrasonographic measurements and clinical questionnaires, were performed by an assessor blinded to group allocation. Participants and treatment providers were not blinded due to the nature of the interventions.

Intervention model description

Participants were randomly assigned in a 1:1 ratio to one of two parallel treatment groups: pulsed therapeutic ultrasound or pulsed shortwave diathermy. Both groups received standard conservative treatment including wrist splinting and tendon-nerve gliding exercises. Outcome assessments were performed by an assessor blinded to group allocation.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Age between 18 and 65 years * Symptom duration of at least 4 weeks * Diagnosis of mild-to-moderate carpal tunnel syndrome confirmed by electromyography

Exclusion criteria

* Cervical radiculopathy * Brachial plexopathy * Thoracic outlet syndrome * Previous carpal tunnel surgery * Severe carpal tunnel syndrome * Pregnancy * Malignancy * Coagulation disorders * Cardiac pacemaker * Physical therapy for carpal tunnel syndrome within the previous 6 months

Design outcomes

Primary

MeasureTime frameDescription
Change in Median Nerve Cross-Sectional Area (MNCSA)Baseline and 3 monthsChange in ultrasonographically measured median nerve cross-sectional area (mm²) from baseline to 3 months after treatment.

Secondary

MeasureTime frameDescription
Change in Boston Carpal Tunnel Questionnaire ScoreBaseline, 1 month, and 3 monthsChange in Boston Carpal Tunnel Questionnaire total score (including Symptom Severity and Functional Status subscales) from baseline to 1 month and 3 months after treatment. Higher scores indicate worse symptom severity and functional impairment.
Change in Pain Intensity (VAS)Baseline, 1 month, and 3 monthsChange in pain intensity measured by a 10-cm VAS, where 0 indicates no pain and 10 indicates worst imaginable pain, from baseline to 1 month and 3 months.
Change in Neuropathic Pain Score (DN4)Baseline, 1 month, and 3 monthsChange in neuropathic pain severity measured by the DN4 questionnaire (0-10 scale), from baseline to 1 month and 3 months. Higher scores indicate greater neuropathic pain severity.
Change in Grip StrengthBaseline, 1 month, and 3 monthsChange in hand grip strength measured using a hydraulic hand dynamometer (kg), from baseline to 1 month and 3 months.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 5, 2026